Intellipharmaceutics International Inc. Quarterly Accrued Liabilities, Current in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Intellipharmaceutics International Inc. quarterly Accrued Liabilities, Current history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Accrued Liabilities, Current for the quarter ending August 31, 2023 was $3.52M.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.52M Aug 31, 2023 6-K 2023-10-16
Q2 2023 $3.28M May 31, 2023 6-K 2023-09-26
Q4 2022 $2.82M +$549K +24.2% Nov 30, 2022 20-F/A 2024-02-06
Q4 2021 $2.27M +$492K +27.7% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $1.86M +$222K +13.5% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $1.87M +$357K +23.6% May 31, 2021 6-K 2021-07-15
Q1 2021 $1.75M +$612K +53.8% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $1.78M +$853K +91.9% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $1.64M +$467K +39.8% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $1.51M +$581K +62.4% May 31, 2020 6-K 2020-07-15
Q1 2020 $1.14M +$261K +29.9% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $928K +$575K +163% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $1.17M +$432K +58.3% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $932K +$223K +31.5% May 31, 2019 6-K 2019-07-10
Q1 2019 $876K Feb 28, 2019 6-K 2019-04-15
Q4 2018 $353K -$429K -54.9% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $742K Aug 31, 2018 6-K 2018-10-15
Q2 2018 $709K May 31, 2018 6-K/A 2018-07-24
Q4 2017 $782K Nov 30, 2017 6-K 2018-10-15
Q4 2015 $454K -$221K -32.7% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $675K +$6.17K +0.92% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $616K Feb 28, 2014 6-K 2014-04-14
Q4 2013 $669K +$445K +198% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $225K -$211K -48.5% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $436K +$115K +35.9% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $321K Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.